These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23143188)

  • 41. Evaluation of testicular toxicology: a synopsis and discussion of the recommendations proposed by the Society of Toxicologic Pathology.
    Creasy DM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Oct; 68(5):408-15. PubMed ID: 14745990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathology in drug discovery and development.
    Jubb AM; Koeppen H; Reis-Filho JS
    J Pathol; 2014 Jan; 232(2):99-102. PubMed ID: 24122335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commentary on application of refined morphologic evaluation of the testis to the practice of toxicologic pathology.
    Szczech GM; Russell LD
    Toxicol Pathol; 1997; 25(2):230-7. PubMed ID: 9125783
    [No Abstract]   [Full Text] [Related]  

  • 45. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dawning of a new age of toxicology.
    Leist M; Hartung T; Nicotera P
    ALTEX; 2008; 25(2):103-14. PubMed ID: 18551234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assuring safety without animal testing: Unilever's ongoing research programme to deliver novel ways to assure consumer safety.
    Westmoreland C; Carmichael P; Dent M; Fentem J; MacKay C; Maxwell G; Pease C; Reynolds F
    ALTEX; 2010; 27(3):61-5. PubMed ID: 21113564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global recognition of qualified toxicologic pathologists: where we are now and where we need to go.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Toxicol Pathol; 2008 Jul; 36(5):753-9. PubMed ID: 18648095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global recognition of qualified toxicologic pathologists: where we are now and where we need to go.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Exp Toxicol Pathol; 2008 Jun; 60(1):1-8. PubMed ID: 18424010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Applying simulation modeling to problems in toxicology and risk assessment--a short perspective.
    Andersen ME; Clewell HJ; Frederick CB
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):181-7. PubMed ID: 7645013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A toxicologic pathologist's view of apoptosis or I used to call it necrobiosis, but now I'm singing the apoptosis blues.
    Levin S
    Toxicol Pathol; 1995; 23(4):533-9. PubMed ID: 7501966
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulatory Considerations and Evolving Technologies in Toxicologic Pathology. Proceedings of the Society of Toxicologic Pathologists 12th International Symposium. Alexandria, Virginia, June 27-July 1, 1993.
    Toxicol Pathol; 1994; 22(2):85-225. PubMed ID: 7973373
    [No Abstract]   [Full Text] [Related]  

  • 57. High-resolution revolution.
    Manuel J
    Environ Health Perspect; 2002 May; 110(5):A238-9. PubMed ID: 12003766
    [No Abstract]   [Full Text] [Related]  

  • 58. Preparing for the twenty-first century.
    Alden CL
    Toxicol Pathol; 1996; 24(1):1-2. PubMed ID: 8839274
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pathology in the current scientific and technological revolution].
    Brozman M
    Cesk Patol; 1975 Jan; 11(1):2-10. PubMed ID: 1149141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparing for the twenty-first century: report of the TOX-90's Commission. Planning Committee.
    Miya TS; Gibson JE; Hook JB; McClellan RO
    Toxicol Appl Pharmacol; 1988 Oct; 96(1):1-6. PubMed ID: 3188014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.